Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
32nd European Congress on Obesity
Use and Effectiveness of Once-weekly Semaglutide in US Adults with Overweight or Obesity in Clinical Practice
32nd European Congress on Obesity
ECO 2025
11 - 14 May 2025
Use and effectiveness of once-weekly semaglutide in US adults with overweight or obesity in clinical practice
Authors
:
Timothy Arnaut
1
; Riya Arora
2
; João Fernandes
1
Affiliations
View Details
Hide Details
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
RWE